Cigna Group stock tracks new 2030 earnings targets

Published on 09/30/2026 at 15:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cigna Group stock was at EUR 242.85 at Lang & Schwarz on September 30, 2026. The company reaffirmed USD 30.45 adjusted EPS guidance and a 10-14 percent target.

Modernes Bürogebäude eines US-Krankenversicherers mit Glasfassade und gepflegtem Außengelände — Cigna Group Krankenversicherung modernes Unternehmensgebäude mit Glasfassade, ISIN US1255231003, Mitarbeiter gehen zum Eingang, Illustration mit AI erstellt.

Cigna Group (ISIN US1255231003) was trading at EUR 242.85 at Lang & Schwarz on September 30, 2026 at 3:00 p.m. CEST, plus 0.16 percent versus the prior close of EUR 242.45. The company reaffirmed its 2026 adjusted EPS guidance and added long-term targets at its Investor Day.

2030 targets set a longer horizon

As Yahoo Finance reported on September 30, 2026, The Cigna Group reaffirmed adjusted 2026 revenue guidance of USD 280.0 billion and adjusted EPS of at least USD 30.45. The release also set a 10-14 percent adjusted EPS compound annual growth target through 2030 and cumulative operating cash flow of USD 50.0 billion through that year.

The strategy includes a USD 3.0 billion multi-year modernization and productivity initiative. The company linked the program to process modernization, AI-enabled tools and supplier discipline, giving investors a defined spending and growth framework rather than a single-quarter target.

Quarterly earnings beat the EPS estimate

MarketBeat reported that Cigna's second-quarter adjusted EPS reached USD 7.78 on July 30, 2026, versus consensus of USD 7.60. The USD 0.18 beat came as quarterly revenue rose 6.7 percent year over year to USD 70.04 billion, although revenue was below the USD 70.14 billion consensus estimate.

The comparison explains why the Investor Day message matters: earnings conversion exceeded expectations, while the revenue figure remained below the forecast. The newer 2030 framework therefore places the emphasis on sustained adjusted EPS growth, operating cash flow and execution across Evernorth Health Services and Cigna Healthcare.

Analyst target remains above the quote

As MarketScreener reported on September 9, 2026, Evercore ISI began coverage with an In Line rating and a USD 290.00 price target. MarketBeat cited a broader average target of USD 337.10 on September 30, 2026, alongside a Moderate Buy consensus from 23 analysts.

The market context is mixed in magnitude but clear in structure. Cigna's market capitalization was USD 72.7 billion on September 29, 2026, while its NYSE 52-week range stood at USD 239.51 to USD 315.47, leaving the Lang & Schwarz euro quote above the lower end of the corresponding US-dollar range only as separate venue context.

Lang & Schwarz quote stays nearly flat

Cigna Group stock was trading at EUR 242.85 at Lang & Schwarz on September 30, 2026 at 3:00 p.m. CEST, up 0.16 percent from the EUR 242.45 prior close. The small daily move leaves the Investor Day targets and the 2026 EPS floor as the main quantified reference points for the stock.